Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Everything we know about Mounjaro, new NHS weight loss jab
Weight-loss drug Mounjaro will help 'so many' people, say users
Weight-loss drug Mounjaro is set to be rolled out on the NHS in England from March. It is one of many weight-loss drugs that have become increasingly popular in recent years, and are sold privately by clinics and pharmacies.
Mounjaro, the ‘King Kong’ of weight loss jabs, will be available in Ireland early next year
A new drug dubbed the “King Kong” of weight-loss jabs will be available in Ireland early next year, it was confirmed yesterday.
What is Mounjaro? The new NHS weight loss jab with a 12-year wait
Warning it is ‘not a magic bullet’, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, said: ‘Weight loss drugs, such as tirzepatide, are an important tool in helping people lose weight while also reducing the risk of other serious long-term conditions such as diabetes, strokes and heart attacks.
NHS gets 12 years to roll out new weight-loss drug Mounjaro
A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the NHS drugs advisory body says. The National Institute for Health and Care Excellence (NICE) final draft guidance on Mounjaro has recommended it starts being given from March, alongside advice on diet and exercise.
Obese people ‘will have to wait’ for weight loss jab Mounjaro, NHS officials warn
However, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, warned that weight loss jabs “are not a magic bullet”.
Mounjaro: NICE sets out £317m annual NHS weight loss jab rollout
The “first” NHS Mounjaro patients of a possible 3.4 million are set to receive the weight loss jab by March 2025, NICE has revealed in new draft guidance, while the first generic GLP-1 weight loss drug could soon follow.
Who can get new weight-loss jab Mounjaro on the NHS?
The rollout of the weight-loss drug to 3.4 million eligible patients could take up to 12 years, according to NICE.
Weight loss drug Mounjaro will be available via the NHS for some people living with obesity
Weight loss jab tirzepatide – commonly sold under the brand name Mounjaro – is set to become available via the NHS for eligible patients in England. It could take up to 12 years for everyone who meets the criteria to actually receive it,
The ‘King Kong of weight-loss drugs’ – what is Mounjaro and who will be eligible for it?
The ‘King Kong of weight-loss drugs’ – what is Mounjaro and who will be eligible for it? - Fewer than 10% of patients in England who are eligible will initially be able to access it on the NHS.
23h
on MSN
Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, Zepbound
Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some ...
9d
Mounjaro Lawsuits (2024 Update)
Mounjaro is a treatment for Type 2 diabetes that activates GIP and GLP-1 pathways to help regulate blood sugar. It’s part of ...
FiercePharma
2d
For first phase of Mounjaro's obesity rollout in England, only a limited number of patients will have access
Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care ...
pharmaphorum
1d
Mounjaro cleared for NHS use, but patients may have to wait
Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people ...
Daily Mail
28d
Mounjaro WRECKED my health, I wish I'd never taken it - patients reveal disastrous side effects of jab as UK reports first death from weight loss drugs
Tirzepatide, available as
Mounjaro
, has been hailed as the 'King Kong' of slimming jabs and a breakthrough in the war on obesity — more effective for shifting the pounds than similar drugs like ...
10h
Eli Lilly CEO says Mounjaro maker may consider other Wisconsin sites for new plants
Fast-growing drugmaker Eli Lilly and Co. would consider Wisconsin sites for new plants beyond a $3 billion project the ...
BioPharma Dive
12h
Lilly adds to obesity drug production push with $3B investment
The expansion of a newly acquired facility in Wisconsin is Lilly’s largest U.S. manufacturing investment outside of Indiana ...
1d
on MSN
Lilly to Boost Obesity Drug Supply With $3 Billion Expansion
Eli Lilly & Co. is spending another $3 billion to build out its US manufacturing footprint as it ramps up production of its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Zepbound
Eli Lilly
Wisconsin
Weight loss
United Kingdom
Feedback